| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = -$211,366 ) |
| 2025 | 2022 | DIMAGI INC | 585 MASSACHUSETTS AVE | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | Cancer Cause and Prevention Research | 000 | 3 | 2/3/2025 | NON-COMPETING CONTINUATION | -$211,366 |
|
 | Issue Date FY: 2022 ( Subtotal = $736,762 ) |
| 2022 | 2022 | DIMAGI, INC. | 585 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | Cancer Cause and Prevention Research | 001 | 3 | 8/14/2022 | NON-COMPETING CONTINUATION | $736,762 |
| 2022 | 2021 | DIMAGI, INC. | 585 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | Cancer Cause and Prevention Research | 000 | 2 | 11/24/2021 | COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2021 ( Subtotal = $764,805 ) |
| 2021 | 2021 | DIMAGI, INC. | 585 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02139 | MIDDLESEX | USA | Cancer Cause and Prevention Research | 000 | 2 | 9/21/2021 | COMPETING CONTINUATION | $764,805 |
|
|